AURKA and glioblastoma: A recently discovered OXID-pyridonyl derivative named SA16 was shown to be a dual PDK1/AurA pathway inhibitor which successfully reduces cell proliferation and invasiveness, while inducing the differentiation and subsequent apoptosis of GMB stem-like cells, therefore reducing their population and pointing towards a solution to GBM chemoresistance [109].